China Molecular Diagnostics Market & Volume Forecast, by Application [Oncology Testing, Infectious Disease Testing, and Genetic Disease Testing]
- Renub Research
- October 2020
- Molecular Diagnostics
- 100 pages
Molecular diagnostics plays an important role in the identification of diseases and has gained more public & healthcare specialist attention than ever before. The molecular diagnostics is a technique used for the molecular biological detection of any change in the structure or expression of a patient's genetic material. According to Renub Research, China Molecular Diagnostics Market is expected to be US$ 6.3 Billion by 2026.
In recent years, Molecular diagnostics has changed the face of clinical laboratories by offering easy to use automated molecular systems that provide rapid results with less hands-on time. However, huddles for China diagnostic companies are Lack of Government Support, Public Awareness for Molecular Diagnostics test.
COVID-19 effect on Molecular Diagnostics Industry
Besides, COVID-19 has worked as a catalyst for molecular diagnostics industry in China. In order to spread the disease government of China is doing massive number of COVID test. The types of tests which are done to indentify the coronavirus disease are RT-PCR, and rapid anti-body tests also known as serological tests. RT-PCR is considered the ‘gold standard’ frontline test. In this test testing is done by taking a nasal/throat swab from a patient. This test involves extracting ribonucleic acid or RNA, which is the genetic material of the virus. This is a fairly expensive test it requires RNA extracting machines, a laboratory and trained technicians. On the other hand rapid anti-body tests are portable, administered on-site, provide quick answers and are inexpensive too.
China molecular diagnostics market is segmented into three main categories: Oncology Test, Infectious Disease Test and Genetic Disease Test. Further, Oncology Test has been segmented into three types: Prostate Cancer, Colorectal Cancer and Breast Cancer. Infectious Disease Test has been further categorized into two main types, which is virology and HPV. Genetic Test has been categorized into HLA and Blood Screening. Blood screening test is a dominating segment in the China molecular genetic testing market. According to Renub Research analysis nearly 441 million molecular diagnostic tests will be performed in China by the end of 2026 of which Virology accounts for one of the most performed tests segments.
DICON Clinical Laboratories, Zhejiang Di’an Diagnostics Technology Co., Ltd, Kindstar Global, BGI-Shenzhen, A, Guangzhou Kingmed Diagnostics Center Co. Ltd and OriGene Technologies holds majority of market share in China. However, restriction on export is expected to have minimal impact on the manufacturers as the demand is very high in China which is creating a robust revenue pool for manufacturers dealing in the molecular diagnostics sector.
Renub Research report titled “China Molecular Diagnostics Market, Volume, by Application [Oncology Testing (Breast Cancer, Colorectal Cancer, Prostate Cancer), Infectious Disease Testing (Virology, HPV), and Genetic Disease Testing (Blood Screening, HLA)]” provides a complete analysis of China Molecular Diagnostics Market.
The report studies the market and volume of the following segments in Molecular Diagnostics: Infectious Disease Testing (Virology, HPV), Oncology Testing (Breast Cancer, Colorectal Cancer, Prostate Cancer), and Genetic Disease Testing (Blood Screening, HLA).
Segment Covered in this report are as follows:
Oncology Testing Market and Volume
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
Infectious Disease Testing Market and Volume
Genetic Testing Market and Volume
- Blood Screening
Profiles of Private Clinical Labs and Diagnostic Services Companies in China
- Zhejiang Di’an Diagnostics Technology Co., Ltd
- ADICON Clinical Laboratories
- Guangzhou Kingmed Diagnostics Center Co. Ltd.
- Kindstar Global (Privately held)
- BGI-Shenzhen (Privately held)
- OriGene Technologies (Privately held)
Have query on this report?Make an Enquiry
Table of Content
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Driver
5. China Molecular Diagnostic Market & Test Volume
5.1 China Molecular Diagnostic Market
5.2 China Molecular Diagnostic Test Volume
List of Tables
Table 3?1: China – Major Diagnostic Reagent R&D and Manufacturing Companies in Infectious Diseases, 2010
Table 3?2: Number of hospital beds for every 1,000 people
Table 5?1: China – Molecular Diagnostic Application Market Share (Percent), 2015 – 2019
Table 5?2: China – Forecast for Molecular Diagnostic Application Market Share (Percent), 2020 – 2026
Table 5?3: China – Molecular Genetic Test Market Share (Percent), 2015 – 2019
Table 5?4: China – Forecast for Molecular Genetic Test Market Share (Percent), 2020 – 2026
Table 5?5: China – Molecular Infectious Disease Test Market Share (Percent), 2015 – 2019
Table 5?6: China – Forecast for Molecular Infectious Disease Test Market Share (Percent), 2020 – 2026
Table 6?1: China – Molecular Diagnostic Test Volume Application Share (Percent), 2015 – 2019
Table 6?2: China – Forecast for Molecular Diagnostic Test Volume Application Share (Percent), 2020 – 2026
Table 6?3: China – Molecular Infectious Disease Test Volume Share (Percent), 2015 – 2019
Table 6?4: China – Forecast for Molecular Infectious Disease Test Volume Share (Percent), 2020 – 2026
Table 6?5: China – Molecular Genetic Test Volume Share (Percent), 2015 – 2019
Table 6?6: China – Forecast for Molecular Genetic Test Volume Share (Percent), 2020 – 2026
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Molecular Diagnostics
Molecular DiagnosticsGlobal Molecular Diagnostics Market Research Report 2017
Molecular DiagnosticsGlobal Molecular Diagnostics in Cancer Testing Market Research Report 2017
Molecular DiagnosticsUnited States Molecular Diagnostics Market Report 2017
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017